Search results
Earnings call: Editas Medicine outlines strategic pillars for 2024 By Investing.com
Investing.com· 6 days agoThe company emphasized its strategy, which includes advancing its gene editing therapy reni-cel...
Huawei flagship store surge in China signals showdown with Apple
Reuters via AOL· 9 hours agoHuawei is revamping its retail strategy and aggressively opening flagship stores in China, with some...
Huawei flagship store openings surge in China, signaling showdown with Apple
Reuters via Yahoo Finance· 9 hours agoHuawei is revamping its retail strategy and aggressively opening flagship stores in China, with some...
Goodix Unveils New Ultrasonic Fingerprint Solution with vivo Flagship to Foster Widespread Adoption
WPRI Providence· 2 days agoThe solution features an efficient design, easy integration, optimized processes, and cost effectiveness to drive the widespread commercial adoption of ultrasonic fingerprint technology. SHENZHEN ...
How to Calm Your Fear of Flying
Time via Yahoo News· 5 days agoWith one technique, for example—called imaginal exposure—you might be asked to visualize the process of going to the airport, boarding the plane, and...
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC - Communications Biology
Nature· 2 days agoAn orally available VHL-ERα PROTAC was developed that showed excellent degradation in vitro. When dosing in vivo, the degradation of ERα was lower than expected, due to competitive ...
Vitol to invest $550 million in clean cooking in Africa
Reuters· 23 hours agoCommodities trader Vitol [RIC:RIC:VITOLV.UL] and its unit Vivo Energy intend to invest more than...
The Manchester City machine sputters, but sneaks past Tottenham to the cusp of another EPL title
WSOC-TV Charlotte· 13 hours agoFor 50-plus minutes, the Manchester City machine sputtered. It had roared to the cusp of a...
Poco F6 Pro Price, Key Features Revealed Ahead of May 23 Global Launch
Gadgets 360· 5 hours agoPoco F6 5G is confirmed to launch in India and globally on May 23. There will also be a Poco F6 Pro...
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
GuruFocus.com via Yahoo Finance· 5 days agoThe company, a pioneer in CRISPR/Cas9-based therapeutics, is steering groundbreaking trials in gene editing, targeting severe genetic disorders with its innovative in vivo ...
